Recombinant Tissue Plasminogen Activator for the Treatment of Lower Extremity Peripheral Vascular Occlusive Disease

This publication has 30 references indexed in Scilit:

• Recombinant human tissue-type plasminogen activator is an effective agent for thrombolysis of peripheral arteries and bypass grafts: Preliminary report
  Journal of Vascular Surgery, 1989
• Local thrombolytic therapy of acute peripheral arterial ischaemia with tissue plasminogen activator: A dose-ranging study
  British Journal of Surgery, 1988
• Low Doses of Recombinant Human Tissue-Type Plasminogen Activator for Local Thrombolysis in Peripheral Arteries
  Radiology, 1988
• Femoro-popliteal artery thrombolysis with intra-arterial infusion of recombinant tissue-type plasminogen activator—report of a pilot trial
  European Journal of Vascular Surgery, 1988
• Thrombolysis in myocardial infarction (TIMI): Comparative studies of coronary reperfusion and systemic fibrinogenolysis with two forms of recombinant tissue-type plasminogen activator
  Journal of the American College of Cardiology, 1987
• Thrombolytic therapy with recombinant human tissue-type plasminogen activator: a comparison of two doses.
  Radiology, 1987
• A multicenter, randomized, placebo-controlled trial of a new form of intravenous recombinant tissue-type plasminogen activator (activase) in acute myocardial infarction
  Journal of the American College of Cardiology, 1987
• RANDOMISED TRIAL OF INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS INTRAVENOUS STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTION
  The Lancet, 1985
• Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial.
  Circulation, 1984
• SPECIFIC LYSIS OF AN ILIOFEMORAL THROMBUS BY ADMINISTRATION OF EXTRINSIC (TISSUE-TYPE) PLASMINOGEN ACTIVATOR
  The Lancet, 1981